{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,18]],"date-time":"2024-08-18T04:28:39Z","timestamp":1723955319415},"reference-count":44,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"28","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1097\/md.0000000000001118","type":"journal-article","created":{"date-parts":[[2015,7,16]],"date-time":"2015-07-16T11:26:56Z","timestamp":1437046016000},"page":"e1118","source":"Crossref","is-referenced-by-count":2,"title":["Critical Illness Neuromyopathy Complicating Akinetic Crisis in Parkinsonism"],"prefix":"10.1097","volume":"94","author":[{"given":"Margherita","family":"Capasso","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Vittoria","family":"De Angelis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Di Muzio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Anzellotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Bonanni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Astrid","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Onofrj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-16-20210309","first-page":"1278","article-title":"Therapy of akinetic crises in German.","volume":"24","author":"Danielczyk","year":"1973","journal-title":"Med Welt"},{"issue":"suppl 3","key":"R2-16-20210309","doi-asserted-by":"crossref","first-page":"S233","DOI":"10.1016\/S1353-8020(09)70821-1","article-title":"Emergencies in parkinsonism: akinetic crisis, life-threatening dyskinesias, and polyneuropathy during L-Dopa gel treatment.","volume":"15","author":"Onofrj","year":"2009","journal-title":"Parkinsonism Relat Disord"},{"key":"R3-16-20210309","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1212\/01.WNL.0000157058.17871.7B","article-title":"Acute akinesia in Parkinson disease.","volume":"64","author":"Onofrj","year":"2005","journal-title":"Neurology"},{"key":"R4-16-20210309","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1055\/s-2008-1041226","article-title":"Neuroleptic malignant syndrome or parkinsonism hyperpyrexia syndrome.","volume":"11","author":"Granner","year":"1991","journal-title":"Semin Neurol"},{"key":"R5-16-20210309","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1002\/mds.20325","article-title":"Movement disorder emergencies.","volume":"20","author":"Kipps","year":"2005","journal-title":"Mov Disord"},{"issue":"suppl 1","key":"R6-16-20210309","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1016\/S1353-8020(02)00122-0","article-title":"A collaborative study on the malignant syndrome in Parkinsons disease and related disorders.","volume":"9","author":"Takubo","year":"2003","journal-title":"Parkinsonism Relat Disord"},{"key":"R7-16-20210309","doi-asserted-by":"crossref","first-page":"2792","DOI":"10.1001\/jama.1985.03360190098033","article-title":"A neuroleptic malignantlike syndrome due to levodopa therapy withdrawal.","volume":"254","author":"Friedman","year":"1985","journal-title":"JAMA"},{"key":"R8-16-20210309","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1002\/mds.20689","article-title":"Akinetic crisis, acute akinesia, neuroleptic malignant-like syndrome, parkinsonism-hyperpyrexia syndrome, and malignant syndrome are the same entity and are often independent of treatment withdrawal.","volume":"20","author":"Thomas","year":"2005","journal-title":"Mov Disord"},{"key":"R9-16-20210309","first-page":"399","article-title":"Twenty-five years of amantadine therapy in Parkinsons disease.","volume":"46","author":"Danielczyk","year":"1995","journal-title":"J Neural Transm Suppl"},{"key":"R10-16-20210309","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1002\/mds.1133","article-title":"Treatment of neuroleptic malignant syndrome with subcutaneous apomorphine monotherapy.","volume":"16","author":"Wang","year":"2001","journal-title":"Mov Disord"},{"key":"R11-16-20210309","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.2169\/internalmedicine.31.1298","article-title":"Successful treatment of levodopa-induced neuroleptic malignant syndrome (NMS) with disseminated intravascular coagulation (DIC) in a patient with Parkinsons disease.","volume":"31","author":"Yamawaki","year":"1992","journal-title":"Intern Med"},{"key":"R12-16-20210309","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0952-8180(93)90092-S","article-title":"Successful treatment of an episode of malignant hyperthermia using a large dose of dantrolene.","volume":"5","author":"Blank","year":"1993","journal-title":"J Clin Anesth"},{"issue":"suppl 1","key":"R13-16-20210309","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/S1353-8020(02)00123-2","article-title":"Prevention and treatment of malignant syndrome in Parkinsons disease: a consensus statement of the malignant syndrome research group.","volume":"9","author":"Ikebe","year":"2003","journal-title":"Parkinsonism Relat Disord"},{"key":"R14-16-20210309","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1136\/jnnp.74.5.574","article-title":"Efficacy of methylprednisolone pulse therapy on neuroleptic malignant syndrome in Parkinsons disease.","volume":"74","author":"Sato","year":"2003","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R15-16-20210309","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/S1474-4422(11)70178-8","article-title":"Critical illness polyneuropathy and myopathy: a major cause of muscle weakness and paralysis.","volume":"10","author":"Latronico","year":"2011","journal-title":"Lancet Neurol"},{"key":"R16-16-20210309","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1002\/mus.23615","article-title":"Electrophysiology of neuromuscular disorders in critical illness.","volume":"47","author":"Lacomis","year":"2013","journal-title":"Muscle Nerve"},{"key":"R17-16-20210309","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ccc.2007.10.004","article-title":"Mechanisms of neuromuscular dysfunction in critical illness.","volume":"24","author":"Khan","year":"2008","journal-title":"Crit Care Clin"},{"key":"R18-16-20210309","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1016\/S1388-2457(01)00572-7","article-title":"Electrophysiologic studies critical illness associated weakness: myopathy or neuropathy-a reappraisal.","volume":"112","author":"Trojaborg","year":"2001","journal-title":"Clin Neurophysiol"},{"issue":"suppl 1","key":"R19-16-20210309","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S1353-8020(02)00139-6","article-title":"Preface: malignant syndrome in Parkinsons disease.","volume":"9","author":"Narabayashi","year":"2003","journal-title":"Parkinsonism Relat Disord"},{"issue":"suppl 1","key":"R20-16-20210309","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1016\/S1353-8020(02)00124-4","article-title":"Clinical features of malignant syndrome in Parkinsons disease and related neurological disorders.","volume":"9","author":"Harada","year":"2003","journal-title":"Parkinsonism Relat Disord"},{"issue":"suppl 1","key":"R21-16-20210309","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/S1353-8020(02)00125-6","article-title":"Malignant syndrome in Parkinsons disease: concept and review of the literature.","volume":"9","author":"Mizuno","year":"2003","journal-title":"Parkinsonism Relat Disord"},{"key":"R22-16-20210309","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1002\/ana.410400415","article-title":"Acute myopathy of intensive care: clinical, electromyographic, and pathological aspects.","volume":"40","author":"Lacomis","year":"1996","journal-title":"Ann Neurol"},{"key":"R23-16-20210309","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1093\/brain\/110.4.819","article-title":"Critical illness polyneuropathy. A complication of sepsis and multiple organ failure.","volume":"110","author":"Zochodne","year":"1987","journal-title":"Brain"},{"key":"R24-16-20210309","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/MCC.0b013e328336a229","article-title":"Presentation and management of ICU myopathy and neuropathy.","volume":"16","author":"Latronico","year":"2010","journal-title":"Curr Opin Crit Care"},{"key":"R25-16-20210309","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1113\/jphysiol.2002.035188","article-title":"Crucial role of sodium channel fast inactivation in muscle fibre inexcitability in a rat model of critical illness myopathy.","volume":"547","author":"Rich","year":"2003","journal-title":"J Physiol"},{"key":"R26-16-20210309","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1172\/JCI36570","article-title":"Inactivation of sodium channels underlies reversible neuropathy during critical illness in rats.","volume":"119","author":"Novak","year":"2009","journal-title":"J Clin Invest"},{"key":"R27-16-20210309","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/mus.20907","article-title":"Possible role for nitric oxide dysregulation in critical illness myopathy.","volume":"37","author":"Capasso","year":"2008","journal-title":"Muscle Nerve"},{"key":"R28-16-20210309","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/00044067-200401000-00006","article-title":"Inactivity and inflammation: selected cytokines as biologic mediators in muscle dysfunction during critical illness.","volume":"15","author":"Winkelman","year":"2004","journal-title":"AACN Clin Issues"},{"key":"R29-16-20210309","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1212\/WNL.55.6.854","article-title":"Apoptotic features accompany acute quadriplegic myopathy.","volume":"55","author":"Di Giovanni","year":"2000","journal-title":"Neurology"},{"key":"R30-16-20210309","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1002\/(SICI)1097-4598(199703)20:3<316::AID-MUS8>3.0.CO;2-E","article-title":"Acute quadriplegic myopathy: analysis of myosin isoforms and evidence for calpain-mediated proteolysis.","volume":"20","author":"Showalter","year":"1997","journal-title":"Muscle Nerve"},{"key":"R31-16-20210309","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1002\/1097-4598(200008)23:8<1270::AID-MUS18>3.0.CO;2-E","article-title":"Analysis of muscle proteins in acute quadriplegic myopathy.","volume":"23","author":"Matsumoto","year":"2000","journal-title":"Muscle Nerve"},{"key":"R32-16-20210309","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1111\/j.1399-6576.2009.01952.x","article-title":"Signs of critical illness polyneuropathy and myopathy can be seen early in the ICU course.","volume":"53","author":"Ahlbeck","year":"2009","journal-title":"Acta Anaesthesiol Scand"},{"key":"R33-16-20210309","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0140-6736(02)09459-X","article-title":"Association between mitochondrial dysfunction and severity and outcome of septic shock.","volume":"360","author":"Brealey","year":"2002","journal-title":"Lancet"},{"key":"R34-16-20210309","doi-asserted-by":"crossref","first-page":"E1044","DOI":"10.1152\/ajpendo.00218.2006","article-title":"Derangements in mitochondrial metabolism in intercostal and leg muscle of critically ill patients with sepsis-induced multiple organ failure.","volume":"291","author":"Fredriksson","year":"2006","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"suppl 1","key":"R35-16-20210309","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/SHK.0b013e31828fade1","article-title":"Bioenergetics, mitochondrial dysfunction, and oxidative stress in the pathophysiology of septic encephalopathy.","volume":"39","author":"Bozza","year":"2013","journal-title":"Shock"},{"key":"R36-16-20210309","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1590\/S1807-59322011001000024","article-title":"Sepsis-associated encephalopathy: not just delirium.","volume":"66","author":"Zampieri","year":"2011","journal-title":"Clinics (Sao Paulo)"},{"key":"R37-16-20210309","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1097\/CCM.0b013e3181760c4b","article-title":"Sepsis induces brain mitochondrial dysfunction.","volume":"36","author":"dAvila JC, Santiago","year":"2008","journal-title":"Crit Care Med"},{"key":"R38-16-20210309","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1111\/j.1471-4159.1990.tb02325.x","article-title":"Mitochondrial complex I deficiency in Parkinsons disease.","volume":"54","author":"Schapira","year":"1990","journal-title":"J Neurochem"},{"key":"R39-16-20210309","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1111\/ene.12364","article-title":"Recurrent and fatal akinetic crisis in genetic-mitochondrial parkinsonisms.","volume":"21","author":"Bonanni","year":"2014","journal-title":"Eur J Neurol"},{"key":"R40-16-20210309","doi-asserted-by":"crossref","first-page":"e649","DOI":"10.1097\/MD.0000000000000649","article-title":"Dopamine transporter single-photon emission computerized tomography supports diagnosis of akinetic crisis of parkinsonism and of neuroleptic malignant syndrome.","volume":"94","author":"Martino","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"R41-16-20210309","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0022-510X(94)90248-8","article-title":"Mitochondrial respiratory failure in skeletal muscle from patients with Parkinsons disease and multiple system atrophy.","volume":"125","author":"Blin","year":"1994","journal-title":"J Neurol Sci"},{"key":"R42-16-20210309","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1212\/WNL.43.11.2258","article-title":"Mitochondrial respiratory chain activity in skeletal muscle from patients with Parkinsons disease.","volume":"43","author":"Cardellach","year":"1993","journal-title":"Neurology"},{"key":"R43-16-20210309","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0379-0738(00)00323-6","article-title":"An autopsy case of neuroleptic malignant syndrome (NMS) and its immunohistochemical findings of muscle-associated proteins and mitochondria.","volume":"115","author":"Kubo","year":"2001","journal-title":"Forensic Sci Int"},{"key":"R44-16-20210309","doi-asserted-by":"crossref","first-page":"101","DOI":"10.4103\/1673-5374.125337","article-title":"Critical illness polyneuropathy and myopathy: a systematic review.","volume":"9","author":"Zhou","year":"2014","journal-title":"Neural Regen Res"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000001118","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:46:22Z","timestamp":1620960382000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201507030-00016"}},"subtitle":["Report of 3 Cases"],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":44,"journal-issue":{"issue":"28","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000001118","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]}}}